ALLR
Allarity Therapeutics
ALLR
ALLR
2 hedge funds and large institutions have $11.7K invested in Allarity Therapeutics in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$9.94K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$1.72K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
$0 |
| 2 |
VF
Virtu Financial
New York
|
$0 |
| 3 |
Wells Fargo
San Francisco,
California
|
$11 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $9.94K | +$9.94K | +55 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1.72K | +$172 | +1 | +11% |
|
|
3
Wells Fargo
San Francisco,
California
| $11 | -$18 | – | – |
|
4
Morgan Stanley
New York
| $2 | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$20.7K | -63 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$8K | -25 | Closed |
|